AlphaYouMU
Insider selling
Marshall Urist sold $236K of Royalty Pharma plc (RPRX) stock
Marshall Urist, EVP, Research & Investments of Royalty Pharma plc (RPRX), sold 4,126 shares of RPRX stock worth $236K, per an SEC Form 4 filed Oct 5, 2026.
The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.
The trade was reported on Oct 5, 2026.
RPRX has moved +0.0% since the trade date, from $56.66 to $56.66 (Oct 5, 2026 close).
- Traded
- Oct 5, 2026
- Disclosed
- Oct 5, 2026
- Filing delay
- 0 days
- Price since
- +0.0%
- Role
- EVP, Research & Investments
- Source
- SEC Form 4
More RPRX insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.